India to South Africa: Salmeterol Export Trade Route

The India to South Africa Salmeterol corridor is one of India's established pharmaceutical export routes, with 74 shipments documented worth a combined $3.8M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 93% of all export value, reflecting the consolidated nature of India's salmeterol manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $51.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during January–March, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 17.1%, placing it at rank #9 among India's top salmeterol export destinations globally.

On the import side, key buyers of Indian salmeterol in South Africa include MEDPRO PHARMACEUTICA PTY LTD, MEDPRO PHARMACEUTICA (PTY) LTD, MEDPRO PHARMACEUTICA (PTY) LIMITED and 9 others. MEDPRO PHARMACEUTICA PTY LTD is the single largest importer with 27 shipments valued at $1.4M USD.

India's salmeterol exports to South Africa are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 70 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in South Africa benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED — together account for 100% of total trade value on this route. The average shipment value of $51.6K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as sereflo 25 250 hfa inhaler with gentle haler salmeterol xinafoate 25mcg fluticasone propionate 250mcg p s 1x120 md and sereflo 25/250 hfa inhaler with gentlehaler (salmeterol xinafoate 25mcg+fluticasone propionate 250mcg )nos, suggesting that buyers in South Africa tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MEDPRO PHARMACEUTICA PTY LTD is the largest importer with 27 shipments worth $1.4M USD — representing 37% of all salmeterol imports from India on this route. A total of 12 buyers are active on this corridor.